wet- en regelgeving RNAi Therapy Gets Breakthrough Status for Primary Hyperoxaluria Type 1 17 juli 2019Monthly Prescribing Reference (MPR): Drugs in the Pipeline
wet- en regelgeving Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients 17 juli 2019InPharm.com
wet- en regelgeving Crizanlizumab Granted Priority Review for Sickle Cell Pain Crises Prevention 17 juli 2019Monthly Prescribing Reference (MPR): Drugs in the Pipeline
marketing Wetenschap vs praktijk: wat is de meest succesvolle (marketing)strategie? 15 juli 2019MarketingTribune
